Seven Grand Managers’s Aktis Oncology AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$487K Hold
25,000
– – 0.02% 149
2026
Q2
$806K Hold
25,000
– – 0.03% 164
2026
Q1
$447K Buy
+25,000
New +$485K 0.03% 166

Other funds holding AKTS

Seven Grand Managers's AKTS Position: Q3 2026 in Review

Seven Grand Managers held its Aktis Oncology (AKTS) position steady in Q3 2026 at 25,000 shares worth $487K. The position accounts for 0.02% of the portfolio, ranked #149.

Seven Grand Managers first reported a position in AKTS in Q1 2026 and has held it in 3 quarters since. The position peaked at $806K in Q2 2026. 125 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • Seven Grand Managers held 25,000 shares of Aktis Oncology worth $487K as of Q3 2026.
  • Seven Grand Managers left its Aktis Oncology share count unchanged in Q3 2026.
  • Aktis Oncology made up 0.02% of Seven Grand Managers's portfolio in Q3 2026, its #149 holding.
  • Seven Grand Managers first reported a position in Aktis Oncology in Q1 2026 and has held it in 3 quarters since.
  • Seven Grand Managers's Aktis Oncology position peaked at $806K in Q2 2026.
  • 125 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.